Awakn’s Psychedelics Medical Chief Steps Down
Press Release Awakn Life Sciences Corp. AWKNF the biotech company developing psychedelic therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD) shared its recent corporate news. Dr. Ben Sessa has resigned from his role as Head of Psychedelic Medicine and will transfer his 49% stake of Awakn Bristol Ltd. to the company’s […]
Go to Source
Powered by WPeMatico
